Antibiotics
Catalog | Product Name / CAS / Description | Structure |
---|---|---|
BBF-01413 |
10,11-dihydropicromycin (27656-56-0) Inquiry |
|
10,11-dihydropicromycin is produced by the strain of Streptomyces venezuelae. It has anti-gram-positive bacterial activity. |
||
BBF-01414 |
16,17-Dihydrorifamycin S (51874-02-3) Inquiry |
|
Produced by the strain of Nocardia mediterranei T101. It has anti-gram-negative bacterial activity. |
||
BBF-01415 |
25-Dihydrosaframycin A (81382-09-4) Inquiry |
|
It is produced by the strain of Rhodococcus amidophilus IFM 144. It has anti-gram-positive bacteria effect and weak activity of anti-gram-negative bacteria and tumor cells. |
||
BBF-01416 |
10-Dihydrosteffimycin A (75086-96-3) Inquiry |
|
It is produced by the strain of Actinoplanes utahensis. 10-Dihydrosteffimycin A has anti-gram-positive bacterial activity. |
||
BBF-01417 |
10-Dihydrosteffimycin B (75086-97-4) Inquiry |
|
It is produced by the strain of Chaetomium sp. BB 427. 10-Dihydrosteffimycin B has anti-gram-positive bacterial activity. |
||
BBF-01418 | ||
Fluoroindolocarbazole A is produced by the strain of Saccharothrothrix aerocolonigenes. Fluoroindolocarbazole A has antitumor effect. |
||
BBF-01419 | ||
Fluoroindolocarbazole B is produced by the strain of Saccharothrothrix aerocolonigenes. Fluoroindolocarbazole B has antitumor effect. |
||
BBF-01420 | ||
Fluoroindolocarbazole C is produced by the strain of Saccharothrothrix aerocolonigenes. Fluoroindolocarbazole C has antitumor effect. |
||
BBF-01421 |
5-Fluoropolyoxin L (50355-67-4) Inquiry |
|
It is produced by the strain of Streptomyces cacoi. 5-Fluoropolyoxin L has the inhibitory activity of Escherichia coli and Streptococcus faecalis, and the antibacterial activity of 5-Fluoropolyoxin M is lower than L. |
||
BBF-01422 |
5-Fluoropolyoxin M (50355-68-5) Inquiry |
|
It is produced by the strain of Streptomyces cacoi. 5-Fluoropolyoxin L has the inhibitory activity of Escherichia coli and Streptococcus faecalis, and the antibacterial activity of 5-Fluoropolyoxin M is lower than L. |
||
BBF-01425 |
Fluvirucin A1 (137019-37-5) Inquiry |
|
Fluvirucin A1 is produced by Actinomycete Q464-31. It has the activity against influenza virus. |
||
BBF-01426 |
Fluvirucin B1 (137428-64-9) Inquiry |
|
Fluvirucin B1 is produced by Actinomycete R359-5. It has the activity against influenza virus. |
||
BBF-01427 |
Formadicin A (99150-60-4) Inquiry |
|
It is produced by the strain of Flexibacter alginolique faciens sp. It has strong activity against kinds of pseudomonas, proteobacteria and alkaline-producing bacilli. |
||
BBF-01428 | ||
It is produced by the strain of Flexibacter alginolique faciens sp. Formadicin C has the strongest activity against some pseudomonas, Proteus and alkali producing bacilli among all components. |
||
BBF-01429 | ||
Formamicin is produced by the strain of Saccharothrix sp. MK27-91F2. It has broad spectrum and strong anti-plant pathogenic fungi activity, with MIC of 0.39-12.5μg/mL. It also has moderate gram-positive bacterial activity. It is cytotoxic. |
||
BBF-01430 | ||
2'-N-formimidoylistamycin B is produced by the strain of Streptomyces tenjimariensis SS-939. It has anti-gram positive bacteria and negative bacteria activity. |
||
BBF-01431 |
2''-N-Formimidoylsporaricin A (107480-97-7) Inquiry |
|
It is produced by the strain of Saccharopolyspora hirsuta subsp. kobensis. It has the activity of anti-gram-positive bacteria and negative bacteria, and also has the antibacterial activity against the aminoglycol-resistant bacteria. |
||
BBF-01432 |
N-Formylfortimicin A (74228-81-2) Inquiry |
|
N-Formylfortimicin A is produced by the strain of Micromonospora SF-1854. It has anti-gram positive and negative bacteria activity. The activity was 8-16 times weaker than that of Fortimycin A, but the effect on Salmonella, pseudomonas, and Streptococcus faecalis is similar to that of Fortimycin A. |
||
BBF-01434 |
3'-O-Forosaminyl-griseusin A (158268-23-6) Inquiry |
|
Produced by the strain of Streptomyces griseus MJ361-48F3, it showed activity against gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) with MIC of 0.39-1.56 μg/mL. |
||
BBF-01435 |
Fortimicin B (54783-95-8) Inquiry |
|
Produced by the strain of Micromonospora olivoasterospora, it has a weak antibacterial activity. |